Calmare Therapeutics Inc (fka CTTC)

[powderbum]

From the Mayo Website:

http://www.mayo.edu/research/clinical-trials/CTS-00103621

Mayo Clinic
Search
Request an Appointment
Find a Doctor
Find a Job
Make a Donation
Log in to Account
Translated Content
Espanol
Portuguese
Arabic
Mandarin
Twitter
Facebook
YouTube
Pinterest
PATIENT CARE
Request an Appointment
Log in to Patient Account
See Treatment & Diagnosis Services
Plan Your Visit
Find a Doctor
Stories
Download Mayo Clinic Patient App

Quality Care
Find out why Mayo Clinic is the right place for your health care. Make an appointment.
HEALTH INFORMATION
Diseases & Conditions A-Z
Symptom Checker
Drugs & Supplements A-Z
Tests & Procedures A-Z
Healthy Living
Expert Blogs
Mayo Clinic Store

Find It Fast
More than 3,300 physicians, scientists and researchers from Mayo Clinic share their expertise to empower you. Manage your health.
RESEARCH
Explore Research Labs
Find Clinical Trials
Research Faculty
Postdoctoral Fellowships
Discovery's Edge Magazine
Search Publications
Training Grant Positions

Research and Clinical Trials
See how Mayo Clinic research and clinical trials advance the science of medicine and improve patient care. Explore now.
DEPARTMENTS & CENTERS
Contact Us
About Mayo Clinic
Doctors & Medical Staff
Medical Departments & Centers
Research Centers & Programs

Meet the Staff
Find a directory of doctors and departments at all Mayo Clinic campuses. Visit now.
MEDICAL EDUCATION
Mayo Graduate School
Mayo Medical School
Mayo School of Continuous Professional Development
Mayo School of Graduate Medical Education
Mayo School of Health Sciences
Alumni Center

Visit Our Schools
Educators at Mayo Clinic train tomorrow’s leaders to deliver compassionate, high-value, safe patient care. Choose a degree.
FOR MEDICAL PROFESSIONALS
Online Services for Referring Physicians
Grand Rounds
Publications
Continuing Medical Education
Mayo Medical Laboratories
Patient Education Materials

Professional Services
Explore Mayo Clinic’s many resources and see jobs available for medical professionals. Get updates.
GIVING TO MAYO CLINIC
Frequently Asked Questions
Make a Donation
Passion With Purpose
Financials

Give to Mayo Clinic
You are an essential partner in our work to find answers for our patients. Donate now.
CLINICAL TRIALS
Clinical TrialsAbout Clinical StudiesDeciding to VolunteerContact
Advanced search
Scrambler Therapy for the Treatment of Chemotherapy Induced Peripheral Neuropathy: An Open Access Trial

LOCATION:
Rochester, Minn.

TRIAL STATUS:
Open for Enrollment
WHY IS THIS STUDY BEING DONE?
OBJECTIVES: I. To record the types of patients that we treat, along with the reported efficacy and potential toxicity associated with scrambler therapy. II. To get experience with patient reported outcome measurement tools that we use in this trial, including a report of analgesic use. OUTLINE: Patients undergo scrambler therapy for 30 minutes daily for up to 10 consecutive days. Treatment continues in the absence of unacceptable toxicity. After completion of study treatment, patients are followed up for 10 weeks. III. To explore neurologic testing changes in patients receiving scrambler therapy.

WHO IS ELIGIBLE TO PARTICIPATE?
Inclusion Criteria: - Pain or symptoms of neuropathy or pain of >= 1 month (30 days) duration for which the patient wants intervention - Participants have to relate that tingling or pain was at least a four out of ten problem during the prior week, on a 0-10 scale where zero was no problem and ten was the worst possible problem and expected to have tingling or pain of at least 4/10 at the time of the first treatment - Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) = 0, 1, or 2 - Life expectancy >= 3 months (90 days) - Case review by the study chair, or designate, as a case where treatment should be tried. - Ability to complete questionnaire(s) by themselves or with assistance - Ability to provide informed written consent Exclusion Criteria: - Pregnant women - Patients with implantable drug delivery systems, e.g. Medtronic Synchromed - Patients with heart stents or metal implants such as pacemakers, automatic defibrillators, aneurysm clips, vena cava clips and skull plates; (metal implants for orthopedic repair, e.g. pins, clips, plates, cages, joint replacements are allowed as are central venous access devices) - Patients with a history of myocardial infarction or ischemic heart disease within the past six months - Patients with history of epilepsy, brain damage, use of anti-convulsants for seizure prevention, concurrently using ketamine, symptomatic brain metastases; Note: anti-convulsant use is allowed for neuropathy and heart failure (HF) if on a stable dose - Skin conditions such as open sores that would prevent proper application of the electrodes - Other medical or other condition(s) that in the opinion of the investigators might compromise the objectives of the study - Currently on gabapentin or pregabalin Note: (because of data that support that patients don't do as well when on gabapentin or pregabalin, all patients on these medications will be weaned off of them prior to study initiation. The study team will provide instructions on how to do this).

LAST UPDATED:
9/5/2013
NCT ID:
NCT01347723
IRB NUMBER:
11-000675